GlassScriptPhysician profile
Maxwell C Poling
NPI 1871039727
$135,531.62
in general payments reported to CMS, 2019-2025
11 companies · $45K in 2025
The $45K reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $969 · 2022: $8,567 · 2023: $26K · 2024: $55K · 2025: $45K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $114K · Travel and Lodging: $8,654 · Food and Beverage: $3,314.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $114,027.50 |
| Travel and Lodging | $8,653.67 |
| Food and Beverage | $3,313.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $130,511.17 | 2021-2025 | Dysport |
| Merz North America, INC. | $3,368.83 | 2021-2025 | Xeomin |
| Abbvie INC. | $762.88 | 2023-2025 | |
| Revance Therapeutics, INC. | $344.33 | 2024-2025 | Daxi |
| Allergan, INC. | $219.12 | 2021 | |
| Musculoskeletal Transplant Foundation INC. | $205.39 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $37.65 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $29.13 | 2024 | |
| Medela LLC | $20.71 | 2022 | |
| Biofrontera INC. | $19.23 | 2023 | Ameluz, Xepi, Bf-Rhodoled |
| Novartis Pharmaceuticals Corporation | $13.18 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maxwell Poling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.